Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Depreciation and Depletion: 2020-2022

Historic Depreciation and Depletion for Caribou Biosciences (CRBU) over the last 2 years, with Jun 2022 value amounting to $400,000.

  • Caribou Biosciences' Depreciation and Depletion rose 100.00% to $400,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $301,000, marking a year-over-year decrease of 66.56%. This contributed to the annual value of $1,000 for FY2021, which is 99.89% down from last year.
  • According to the latest figures from Q2 2022, Caribou Biosciences' Depreciation and Depletion is $400,000, which was up 33.33% from $300,000 recorded in Q1 2022.
  • Over the past 5 years, Caribou Biosciences' Depreciation and Depletion peaked at $400,000 during Q2 2022, and registered a low of -$699,000 during Q4 2021.
  • In the last 3 years, Caribou Biosciences' Depreciation and Depletion had a median value of $300,000 in 2022 and averaged $166,778.
  • In the last 5 years, Caribou Biosciences' Depreciation and Depletion plummeted by 449.50% in 2021 and then skyrocketed by 100.00% in 2022.
  • Quarterly analysis of 3 years shows Caribou Biosciences' Depreciation and Depletion stood at $200,000 in 2020, then slumped by 449.50% to -$699,000 in 2021, then soared by 100.00% to $400,000 in 2022.
  • Its Depreciation and Depletion was $400,000 in Q2 2022, compared to $300,000 in Q1 2022 and -$699,000 in Q4 2021.